Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.

Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR.

J Urol. 2003 Dec;170(6 Pt 1):2279-83.

PMID:
14634396
2.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.

J Urol. 2003 Nov;170(5):1804-7.

3.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR.

J Urol. 2000 Jul;164(1):81-8.

PMID:
10840429
4.

Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.

Carter CA, Donahue T, Sun L, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Jackmaan S, Moul JW.

J Clin Oncol. 2003 Nov 1;21(21):4001-8.

PMID:
14581423
5.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
6.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

7.

Early outcomes of active surveillance for localized prostate cancer.

Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R, Dearnaley D.

BJU Int. 2005 May;95(7):956-60.

9.
10.

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E.

BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.

11.

Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.

Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM.

Ann Intern Med. 2013 Jun 18;158(12):853-60. doi: 10.7326/0003-4819-158-12-201306180-00002.

12.
13.

Active surveillance in men with localized prostate cancer: a systematic review.

Dahabreh IJ, Chung M, Balk EM, Yu WW, Mathew P, Lau J, Ip S.

Ann Intern Med. 2012 Apr 17;156(8):582-90. doi: 10.7326/0003-4819-156-8-201204170-00397. Epub 2012 Feb 20. Review.

PMID:
22351515
14.

An evidence review of active surveillance in men with localized prostate cancer.

Ip S, Dahabreh IJ, Chung M, Yu WW, Balk EM, Iovin RC, Mathew P, Luongo T, Dvorak T, Lau J.

Evid Rep Technol Assess (Full Rep). 2011 Dec;(204):1-341. Review.

15.
16.

Active surveillance for the management of prostate cancer in a contemporary cohort.

Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.

Cancer. 2008 Jun 15;112(12):2664-70. doi: 10.1002/cncr.23502.

17.

Watchful waiting and factors predictive of secondary treatment of localized prostate cancer.

Wu H, Sun L, Moul JW, Wu HY, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D.

J Urol. 2004 Mar;171(3):1111-6.

PMID:
14767282
18.

Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.

Fossati N, Karnes RJ, Cozzarini C, Fiorino C, Gandaglia G, Joniau S, Boorjian SA, Goldner G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T, Briganti A.

Eur Urol. 2016 Apr;69(4):728-33. doi: 10.1016/j.eururo.2015.10.009. Epub 2015 Oct 21.

PMID:
26497924
19.
20.

Five-year nationwide follow-up study of active surveillance for prostate cancer.

Loeb S, Folkvaljon Y, Makarov DV, Bratt O, Bill-Axelson A, Stattin P.

Eur Urol. 2015 Feb;67(2):233-8. doi: 10.1016/j.eururo.2014.06.010. Epub 2014 Jun 30.

Supplemental Content

Support Center